Kisspeptins (Kiss) have been shown to be key components in the regulation of gonadotropin-releasing hormone (GnRH) secretion. In vitro studies have demonstrated an increase in GnRH gene expression by Kiss suggesting regulation of GnRH at both the secretory and pretranslational levels. Here, we define genetic mechanisms that mediate Kiss action on target gene expression. In vitro, sequential deletions of the mouse GnRH (mGnRH) gene promoter fused to the luciferase (LUC) reporter gene localized at kisspeptin-response element (KsRE) between Ϫ3446 and Ϫ2806 bp of the mGnRH gene. In vivo, transgenic mice bearing sequential deletions of the mGnRH gene promoter linked to the LUC reporter localized an identical KsRE. To define the mechanism of regulation, Kiss was first shown to induce nucleosome-depleted DNA within the KsRE, and a potential binding site for the transcription factor, Otx-2, was revealed. Furthermore, increased Otx-2 mRNA, protein, and binding to the KsRE after Kiss treatment were demonstrated. In conclusion, this work identified elements in GnRH-neuronal cell lines and in transgenic mice that mediate positive regulation of GnRH by Kiss. In addition, we show for the first time that Otx-2 is regulated by Kiss, and plays a role in mediating the transcriptional response of mGnRH gene.
Introduction
The GnRH neurons play a critical central role in the regulation of pubertal development and reproduction, hence, the central and peripheral signals and their molecular mechanisms that regulate these cells are important to elucidate.
Most recently, the physiological control of the reproductive axis was advanced by the identification of the essential role of kisspeptin (Kiss), the peptide product of the KiSS-1 gene, and its receptor, G-protein-coupled receptor 54 (GPR54), in the neuroendocrine regulation of reproduction (de Roux et al., 2003; Seminara et al., 2003) . Investigations by many laboratories over the last years have led to the general concept that Kiss-secreting neurons activate GnRH neurons (Roa et al., 2008a; Xu et al., 2011) to advance the complex process of puberty. Furthermore, inactivating mutations of the human GPR54 gene are linked to hypogonadotropic hypogonadism and an absence of puberty (de Roux et al., 2003; Seminara et al., 2003) .
The Kiss-GPR54 signaling pathway has also been implicated in normal reproductive cycling in females (Dungan et al., 2006; Seminara et al., 2006; Lapatto et al., 2007) . Increased GnRH secretion is observed also in adult animals treated with Kiss (Pielecka-Fortuna et al., 2008; Roa et al., 2008b) .
Studies of the role of Kiss on the GnRH neuron have largely focused on cellular secretion of GnRH (Navarro et al., 2005; Gottsch et al., 2006; Roa et al., 2008b) . More recent studies, however, have related GnRH gene expression to secretion in response to Kiss stimulation (Jacobi et al., 2007; Novaira et al., 2009) . In a previous report, we documented in GnRHsecreting neuronal cell lines (GT1-7 and GN11 cells) (Mellon et al., 1990; Radovick et al., 1991) an increase in GnRH secretion and GnRH mRNA levels with Kiss treatment in a doseand time-dependent manner (Novaira et al., 2009) . These data suggest that Kiss affects GnRH expression at both the secretory and pretranslational level.
In addition, the GnRH promoter has been characterized in several previous studies. In vitro experiments have identified several transcription factors (TFs) that interact with GnRH promoter regions to regulate human, rat, and mouse GnRH expression (Kelley et al., 2000; Rave-Harel et al., 2005) . Furthermore, epigenetic mechanisms have been shown to control GnRH gene expression providing an additional level of regulation that could be involved in the developmental and mature function of GnRH neurons (Kurian et al., 2010; Gan et al., 2012) .
In the present studies both GnRH-expressing cell lines and transgenic mice were used as models to explore the molecular mechanisms that regulate GnRH expression by Kiss. The aim of this work was to determine cis-acting GnRH promoter elements, TFs, and chromatin modifications involved in Kiss signaling in GnRH neurons. A kisspeptin-response element (KsRE) located between Ϫ3446 and Ϫ2806 bp in GnRH-neuronal cell lines and in transgenic mice was identified. Furthermore, we show for the first time that Otx-2 is regulated by Kiss and may mediate the transcriptional response of the mouse GnRH (mGnRH) gene.
Materials and Methods
Cell culture. GN11 cells were grown in DMEM (Mediatech) supplemented with 7% fetal bovine serum (FBS) and 3% newborn calf serum (Hyclone) and 25 mM glucose, 5 mM L-glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin (Invitrogen) in an atmosphere with 5% CO 2 at 37°C. GT1-7 cells were grown in a similar manner, except supplemented with 10% heat-inactivated FBS. Cells were placed in media supplemented with 10% dextran and charcoal-stripped serum 24 h before treatment. Cells were treated with kisspeptin-10 (EMD Biosciences) at final concentrations of 10 Ϫ9 M for 0.5, 1, 2, and 4 h for TF mRNA and protein evaluation. Fifteen and 45 min of treatment with kisspeptin-10 was used for chromatin immunoprecipitation assay (ChIP) and formaldehyde-assisted isolation of regulatory elements (FAIRE) assays. Control wells were exposed in parallel to vehicle and are referred to as nontreated groups (NT).
Construction of the mGnRH promoter-luciferase DNA plasmids. A GnRH promoter-luciferase construct containing Ϫ3446 to ϩ23 bp of the mGnRH promoter fused to pSV0aL⌬5Ј luciferase (Ϫ3446/ϩ23 mGnRH-LUC) was kindly provided by Dr. Donald B. DeFranco (University of Pittsburgh, Pittsburgh, PA). This Ϫ3446/ϩ23 mGnRH-LUC was used for transfection experiments in GT1-7 and GN11 cells and to obtain the sequential deletions of the mGnRH promoter to be ligated in the pA3LUC reporter vector. The Ϫ2806/ϩ23 bp mGnRH-LUC construct was previously described in Novaira et al., 2011 , and the Ϫ2078/ϩ23 and Ϫ1005/ϩ23 bp mGnRH-LUC constructs in .The Ϫ1750/ϩ23 and Ϫ587/ϩ23 bp mGnRH-luciferase DNA constructs were previously constructed as a HindIII fragments using PCR and the Ϫ3446/ϩ23 mGnRH-LUC construct as template. PCR was performed in a thermocycler (Gene-Amp PCR System 9600; PerkinElmer), and reaction mixtures contained 5 U Taq polymerase (DisplayTaq; Display Systems Biotech) and 0.5 mM deoxynucleotide triphosphates. The PCR products were restriction enzyme digested with HindIII and ligated into a HindIII linearized, alkaline phosphatase (Roche Molecular Biochemicals) dephosphorylated pA3LUC reporter vector (Maxwell et al., 1989; Wood et al., 1989) . Orientation was checked by sequencing constructs using a primer annealing to the 5Ј end of the luciferase gene.
Transient transfection and cell culture. Transient transfections were performed in GT1-7 and GN11 cell lines. Cells were maintained as described above (see Cell culture). Cells were grown and transfected at 40 -60% confluency. Total DNA was kept constant, and nonspecific effects of viral promoters were controlled using the respective empty pSV0aL⌬5Ј luciferase or the empty pA3LUC vectors for each experiment. Luciferase activities in relative light units (RLUs) were measured at the next day of transfection after 4 h of kisspeptin treatment using the Lumat LB 9507 (Berthold Technologies). Transient transfections were performed in six-well tissue culture plates using a Lipofectamine-plus technique (Invitrogen). A total of 1 g of sequential deletions of mGnRH promoter fused to the luciferase reporter gene was transfected. Transfections were performed in triplicate for each condition within a single experiment, and experiments were repeated at least three times using different plasmid preparations of each construct. The luciferase activity was measured and absolute RLUs were represented as SEM of representative experiments.
Generation of mGnRH promoter-luciferase mice. Transgenic animals were constructed by the University of Chicago Transgenic Facility by pronuclear injection. Briefly, different DNA constructs containing sequential deletions of the mGnRH promoter fused to the LUC reporter gene were used to generate several mGnRH-LUC transgenic mice lines. Fertilized mouse oocytes from CD-1 mice were injected with different purified linear mGnRH-LUC DNA fragments. The resulting embryos were transferred into pseudopregnant foster mothers. Transgenic animals were identified with Southern blot analysis as described previously . Briefly, DNA was isolated from tail snips, restriction enzyme digested with EcoRI, and separated with gel electrophoresis. DNA was then transferred to GeneScreen Plus hybridization transfer membrane (NEN). A 32 P-labeled 1.2 kb probe for luciferase was used to detect transgenic animals that incorporated the luciferase transgene . For identification of luciferase-expressing transgenic lines, neonatal brains were removed from pups, homogenized, and assayed for the mGnRH-LUC transgene as described below.
Assay of mGnRH-luciferase transgene. Adult female and male transgenic LUC mice were housed at the Johns Hopkins Animal facility. All animal studies were approved by the Johns Hopkins Institutional Animal Care Committee. Female mice were cycled and treated with saline solution (control group) or with 1 nmol Kiss intraperitoneally after reaching the diestrus phase of the reproductive cycle. After 4 h of the injection, the hypothalamus of males and females was harvested and LUC activity was measured in RLUs. Briefly, from adult mice, the olfactory and hypothalamic tissue was dissected in a single fragment consisting of tissue from 1 mm caudal to the mammillary bodies, 1 mm laterally beyond the lateral aspect of the median eminence, and 3 mm dorsally. Tissues were placed in 1 ml of lysis buffer (25 mM glycylglycine, 15 mM MgSO 4 , 4 mM EGTA, 1% Triton X-100, and 1 mM dithiothreitol; DTT), and homogenized with a Polytron tissue homogenizer (Brinkmann Instruments). The homogenates were centrifuged at 3000 g for 10 min and the supernatants were assayed for luciferase activity. Luciferase activities were assayed using a Lumat LB 9507 luminometer (Berthold Systems). Samples were injected with 100 l of 0.75 mM luciferin (Invitrogen), dissolved in lysis buffer, and 100 l assay buffer (25 mM glycylglycine, 15 mM MgSO 4 , 4 mM EGTA, 15 mM KPO 4 , 3 mM DTT, and 3 mM ATP) and luminescence were measured for 20 s as RLUs. Because the background RLU (the RLU measured with lysis buffer alone) varied from day to day, we corrected for the background in each experiment. On each day, the luciferase activity was measured in several samples of lysis buffer alone and averaged to obtain a background RLU level for the day. This background value is subtracted from the measured tissue RLU to give a corrected RLU. The corrected RLU reflected the luciferase activity of the tissue.
FAIRE. Genomic isolation of active regulatory elements was detected by FAIRE. GT1-7 and GN11 cells were cultured as described previously and then treated with kisspeptin for 15 and 45 min in a 10 cm plate. FAIRE was performed following the methods described in Giresi and Lieb, 2009. Briefly, after treatment, cells were fixed with 1% formaldehyde in growth medium for 1 min at room temperature. After cell and nuclear lysis, the cross-linked DNA was sheared to ϳ100 -1000 bp lengths by sonication on ice in a Branson Sonifier 250-A (five pulses of 10 s long bursts at power output 3; duty cycle, 50%). Double DNA Phenol/chloroform extraction was performed and RNAase treatment was made. The genomic regions of nucleosome-depleted DNA preferentially segregated into aqueous phase were then mapped back by semiquantitative PCR and quantitative real-time PCR (qRT-PCR) using primers specific to the KsRE, non-KsRE (nKsRE) in the GnRH enhancer (GnRHen), neuron-specific element (NSE), and control elements shown in Table 1 . Mouse FSH-␤ (Coss et al., 2004) and ␤-actin promoters (Huh et al., 2007) were used as negative and positive controls for nucleosomedepleted DNA, respectively. ChIP. ChIP assay was performed using the ChIP-IT Express kit (Active Motif) following the manufacturer's instructions. Briefly, GT1-7 and GN11 cells were cultured as described previously and then treated with kisspeptin for 15 and 45 min. Cells were fixed with 1% formaldehyde in growth medium for 10 min at room temperature. After cell and nuclear lysis, the cross-linked DNA was sheared to ϳ200 -1500 bp lengths by sonication on ice in a Branson Sonifier 250-A (three pulses of 10 s long bursts at power output 3; duty cycle, 50%). The sheared cross-linked chromatin was immunoprecipitated (IP) in dilution buffer and incubated overnight at 4°C with 15 l of anti-OTX2 antiserum generated in rabbits immunized with the peptide SCPAAT-PRKQRRERT (residues 37-51) (Diaczok et al., 2008) or 3 g of normal mouse IgG (sc-2025; Santa Cruz Biotechnology) as a negative control. Protein G magnetic beads (25 l) were added to the samples to collect the immune complexes. After washing the beads, protein-DNA complexes were eluted and reverse cross-linked at 95°C for 15 min by incubation in ChIP elution buffer and then treated with proteinase K. After treatment of the genomic DNA with proteinase K stop solution it was used immediately in quantitative PCR or stored at Ϫ20°C. The input DNA (an aliquot of the sheared chromatin, not subjected to immunoprecipitation, but reverse cross-linked) was diluted to 10% and used to validate the performance of different primer pairs designed to amplify the KsRE, nKsRE in the GnRHen, NSE, and the control elements in the GnRH promoter (Table 1) .
qRT-PCR. RNA was isolated from both cells types and hypothalamic tissues using the TRIzol Reagent (Invitrogen) according to the protocol provided by the supplier. Two micrograms of RNA was reverse transcribed using the iScript cDNA kit (Bio-Rad). qRT-PCR was performed in duplicate using the SyberGreen MasterMix (Bio-Rad) and the ICycler quantitative PCR machine (Bio-Rad Laboratories). Specific primer sequences for GnRH, Otx-2, and 18S were used (Table 1) . To determine PCR efficiency, a 10-fold serial dilution of cDNA was performed as previously described (Wong and Medrano, 2005) . PCR conditions were optimized to generate Ͼ95% PCR efficiency and only those reactions with between 95 and 105% efficiency were included in subsequent analyses. Relative differences in cDNA concentration between baseline and experimental conditions were then calculated using the comparative threshold cycle (C t ) method (Bustin et al., 2005) . Briefly, for each sample, a ⌬C t was calculated to normalize for the internal control using the equation: ⌬C t ϭ C t (gene) Ϫ C t (18S). To obtain differences between experimental and control conditions, ⌬⌬C t was calculated: ⌬C t (sample) Ϫ ⌬C t (control). Relative mRNA levels were then calculated using the equation fold difference ϭ 2 ⌬⌬C t . Western blot analysis. Western blot analysis was performed for OTX-2 protein evaluation in GT1-7 and GN11 cells. Briefly, cellular protein lysates were obtained using cell lysis buffer (#9803; Cell Signaling Technology) and then 10 g total protein was separated on 10% SDS/polyacrylamide gels. Proteins were transferred to Protran nitrocellulose membrane (Whatman GmbH) in Tris/glycine transfer buffer. The membranes were blocked for 1 h with 5% nonfat milk in Tris-buffered saline containing 0.05% Tween 20 (TTBS) at room temperature and then were incubated overnight with anti-OTX2 antiserum generated in rabbits immunized with the peptide SCPAATPRKQRRERT (residues 37-51) (Diaczok et al., 2008) , and with a rabbit polyclonal ␤-actin antibody (#4967; Cell Signaling Technology) as an experimental control. The membranes were washed three times for 10 min with TTBS and incubated for 1 h at room temperature with goat anti-rabbit IgG-horseradish peroxidase conjugate secondary antibody (#172-1019; Bio-Rad). After washing, the blots were visualized using ECL Prime Western blotting detection system (GE Healthcare).
The density of the bands corresponding to the expected size of the protein was analyzed by Quantity One Software for Windows version 4.6 (Bio-Rad Laboratories). Site-directed mutagenesis. The QuikChange Site-Directed Mutagenesis XL Kit (Stratagene) was used to introduce mutations into the KsRE in the Ϫ3446 mGnRH-LUC promoter construct per the manufacturer's instructions. The sequences of the Otx-2 consensus binding site was changed to eliminate Otx-2 binding to the mGnRH gene promoter using primers shown in Table 1 . The TTAT sequences, at Ϫ3005 to Ϫ3002 bp, were mutated to CCGC, introducing a SacII restriction enzyme site, and generating the Ϫ3446 Otx-2 mutant (MUT) LUC. The Otx-2 MUT LUC construct contains mutations in the Otx-2 binding site in the context of the Ϫ3446 mGnRH-LUC reporter construct. The presence of the mutations was confirmed both by restriction enzyme digest and sequencing analysis.
Generation of GnRH neuron-specific Otx-2 knock-out mice. GnRH neuron-specific Otx-2 knock-out (KO) (GnRH-Otx-2KO) mice were previously generated and their reproductive competence were published by Diaczok et al., 2011. Briefly, GnRH-Otx-2KO was created using a mouse line in which the first exon of Otx-2 was flanked by loxP sites and in which cell-specific expression of Cre recombinase under the control of the GnRH promoter causes a loss of Otx-2 expression (Tian et al., 2002) . These mice were crossed with GnRH-Cre mice to specifically target the loxP site recombination to the GnRH neurons of the hypothalamus .
Adult male GnRH-Otx-2KO mice were housed at the Johns Hopkins Animal facility. All animal studies were approved by the Johns Hopkins Institutional Animal Care Committee. Male mice were treated with saline solution (control group) or with 1 nmol Kiss intraperitoneally. After 20 min of the injection, the hypothalamus of males was harvested and qRT-PCR was performed as described above.
Statistical analysis. Statistical significance was assessed by one-way ANOVA followed by the Newman-Keuls multiple-comparison tests. We used an unpaired Student's t test to compare the secretion levels of GnRH between groups treated with kisspeptin-10 and vehicle. All results are expressed as mean Ϯ SEM and p Յ 0.05 assigned as significant using the GraphPad Prism 4 software.
Results
Kiss treatment in GT1-7 and GN11 cells indentified an in vitro KsRE located between ؊3446 and ؊2806 bp on the mGnRH promoter GT1-7 and GN11 cells transfected with sequential deletions of the mGnRH promoter fused to the luciferase reporter gene were treated with 10 Ϫ9 M Kiss for 4 h. Kiss treatment in GT1-7 cells containing the element between Ϫ3446 and ϩ23 bp of the mGnRH promoter had measured LUC activity of 37,600 Ϯ 4374 RLUs, while the nontreated group had LUC activity of 24,397 Ϯ 3513 RLU. This represents a 1.6-fold increase in LUC activity in GT1-7 cells after Kiss treatment (n ϭ 3-4, p Յ 0.05; Fig. 1A ). GN11 cells treated with Kiss had measured LUC activity of 35,549 Ϯ 2089 RLU, while nontreated cells had 24,492 Ϯ 1885 RLU, representing a 1.5-fold increase in LUC activity in GN11 cells after Kiss treatment (n ϭ 3-4, p Յ 0.05; Fig. 1B) . No changes in LUC activity were observed in cells transfected with Ϫ2806 bp or more proximal segments of the GnRH promoter. These data suggest a KsRE located within the region between Ϫ3446 to Ϫ2806 bp of the mGnRH promoter.
A KsRE is identified between ؊3446 and ؊2806 bp of the mGnRH promoter after Kiss injection in GnRH-LUC transgenic mice Since luciferase expression is under the control of the mGnRH promoter, mGnRH promoter activity can be detected and quantitated by measuring luciferase activity in tissue homogenates from transgenic mice containing sequential deletions of the mGnRH promoter fused to the LUC reporter gene. Transgenic mice were treated with saline solution or 1 nmol Kiss intraperitoneally and 4 h after the injection, and brain homogenates were assayed. Female control mice bearing the Ϫ3446/ϩ23 bp GnRH promoter LUC transgene had measured LUC activity of 20,074 Ϯ 457 RLU, while the group treated with Kiss had LUC activity of 41,772 Ϯ 4296 RLU. This represent a twofold (n ϭ 3-5, p Յ 0.05; Fig. 2A ) increase in LUC after Kiss treatment in female mice. Brain homogenates from male control mice had LUC activity of 14,766 Ϯ 3792 RLU and 22,533 Ϯ 121 RLU after Kiss treatment, representing a 1.6-fold increases (n ϭ 3-4, p Յ 0.05; Fig. 2B ). No statistical changes in LUC activities were observed in female or male transgenic mice bearing the Ϫ2806 bp or shorter segments of the GnRH promoter. As in the in vitro studies, a KsRE was located between Ϫ3446 and Ϫ2806 bp of the mGnRH gene. In addition, in both female and male mice the presence of the enhancer element between Ϫ3446 and Ϫ2078 bp of the mGnRH promoter was noted as previously described (Fig. 2 A, B) .
Kiss increases genomic isolation of active regulatory elements at the Otx-2 binding site within the KsRE of the mGnRH promoter Quantities of PCR products corresponding to GnRH regulatory elements (KsRE, nKsRE in the GnRHen, NSE, and the control elements in the GnRH promoter) were measured and compared with ␤-actin and FSH-␤ promoter genes that correspond to ac- tive and inactive promoters in GT1-7 cells, respectively (Iyer et al., 2011) . Initially, semiquantitative PCR products corresponding to GnRH regulatory elements were compared in 1% agarose gels (Fig. 3, right) ; however, qRT-PCR was chosen to increase the sensitivity of detection. FAIRE detected nucleosome-depleted DNA at the Otx-2 binding site located in the KsRE (Ϫ3446 to Ϫ2806 bp) in the nontreated group with the same levels as the ␤-actin gene (active promoter) and increased by proximally sixfold after 15 and 45 min of Kiss treatment (n ϭ 3-4, p Յ 0.05; Fig.  3A, graph) . A small amount of nucleosome-depleted DNA at the Otx-2 binding site located in the non-KsRE (between Ϫ2806 to Ϫ2078 bp) was observed when compared with the FSH-␤ negative control, but no changes were observed after Kiss treatment (n ϭ 3-4, p Ն 0.05; Fig. 3B ). Furthermore, FAIRE performed at Figure4. ChIPinGT1-7cellsfollowedbyqPCR.KissinducesbindingofOtx-2totheKsREinthemGnRHpromoterinGT1-7cells.TheOtx-2bindingsitesareshowninthemodelrepresentation(yellowboxes). Redarrowsrepresenttheprimer'slocalizationusedintheqPCRanalysis.A,Otx-2bindingsiteintheKsREcontainedbetweenϪ3005andϪ3000bponthemGnRHpromoter(yellowboxintheredshading).B, Otx-2bindingsitecontainedbetweenϪ2418andϪ2413bponthemGnRHpromoterlocatedintheGnRHenhancer(nKsRE;yellowboxinthegreenshading).C,Otx-2bindingsitecontainedintheNSE(yellow bow in the blue shading). D, Negative binding control in the GnRH promoter within Ϫ1858 and Ϫ1567 bp (black line). Graphic representation of the means Ϯ SE of relative DNA (qRT-PCR) graphed as fold increase of levels relative to IgG group (black column). Cells were treated with 10 Ϫ9 M Kiss for 15 and 45 min (n ϭ 3, p Յ 0.05). There is no statistical difference between groups with the same letters.
the Otx-2 binding sites located in the NSE (Ϫ1005 to ϩ23 bp) demonstrated that the chromatin is active with no effect noted after kisspeptin treatment in GT1-7 (n ϭ 3-4, p Ն 0.05; Fig. 3D , graph). In addition, there was no evidence of active chromatin in areas between Ϫ1858 and Ϫ1567 bp of the mGnRH promoter, which was used as inactive control elements in this promoter (Fig. 3C) . FAIRE detected nucleosome-depleted DNA from the ␤-actin promoter gene and no changes were observed after Kiss treatment. As expected, no active FSH-␤ promoter elements were detected in these cells.
The KsRE is located in the GnRHen and contains an Otx-2 binding site
Our data demonstrated the presence of a KsRE located between Ϫ3446 and Ϫ2806 bp on the mGnRHen element in GnRHsecreting neuronal cell lines and in GnRH LUC transgenic mice, defining the mGnRHen in two specific regions. The elements contained within Ϫ2806 and Ϫ2078 bp of the GnRHen are nKsRE. This suggests that the sequences necessary to mediate the Kiss effects in neuronal mGnRH expression are contained between Ϫ3446 and Ϫ2806 bp of the GnRHen. These elements were examined for sequences sharing homology with binding sites for the Otx-2 homeodomain protein. The analysis of the GnRH promoter using the DNADynamo software revealed two Otx-2 binding sites located in the GnRHen element, which were not previously described: one between Ϫ3005 and Ϫ3000 bp (GGATTA) and the second between Ϫ2418 to Ϫ2413 bp of the mGnRH promoter (GATAA). Interestingly, the KsRE we described functionally contains the former binding site, which had previously been shown to bind Otx-2 with high affinity (Briata et al., 1999; Kim et al., 2007) . The alignment of the mouse, rat, and human GnRH promoter sequences revealed a high degree of conservation at the Otx-2 site in the KsRE. The Otx-2 sequence motif located from Ϫ3005 to Ϫ3000 in the mouse gene has 83% homology to the rat sequence (located from Ϫ2540 to Ϫ2535), while the comparative region of homology between mouse and human has 100% homology (located from Ϫ3665 to Ϫ3660 in the human gene; data not shown).
Kiss increases binding of Otx-2 to the KsRE in the mGnRH promoter
To evaluate the binding of Otx-2 to the KsRE (Ϫ3005 to Ϫ3000 bp), to the nKsRE in the GnRHen (Ϫ2418 to Ϫ2413 bp) and to the NSE (Ϫ356 to Ϫ249 bp), we performed ChIP in GT1-7 cells followed by qRT-PCR using primers specific to these regulatory elements ( Fig. 4 ; Table 1 ). Initially, semiquantitative PCR products corresponding to GnRH regulatory elements were compared in 1% agarose gels (Fig. 4, right) ; however, qRT-PCR was chosen to increase the sensitivity of detection. Cells treated with 10
Kiss for 15 and 45 min were compared with an NT group. Otx-2 binding to the KsRE increased by Ͼ5-fold in cells treated with Kiss when compared with the NT cells (n ϭ 3, p Յ 0.05; Fig. 4A , graph). There was no significant difference in binding between 15 and 45 min of treatment. Kiss treatment had no effect on Otx-2 binding to the cis-element defined as nKsRE in the GnRHen (n ϭ 3, p Ն 0.05; Fig. 4B, graph) . Interestingly, no changes in the binding of Otx-2 after Kiss treatment were observed within the Otx-2 binding site previously described in the NSE, located between Ϫ356 and Ϫ249 bp of the GnRH promoter (n ϭ 3, p Ն 0.05; Fig. 4C , graph). Since there are no known Otx-2 binding sites between Ϫ1858 and Ϫ1567 bp of the promoter, this region was used as an Otx-2-negative binding control, and indeed ChIP analysis did not reveal binding of Otx-2 within this area (Fig. 4D,  graph) . The qRT-PCR was also performed on input sample dilutions to test the efficiency primers and produce a standard curve for calculating the fold enrichment. A sample immunoprecipitated by IgG antibody was used as negative control of the IP process.
Otx-2 mRNA expression is increased by Kiss in GT1-7 and GN11 cells qRT-PCR was used to evaluate changes in Otx-2 mRNA obtained from both cell lines treated with 10 Ϫ9 M Kiss for 1, 2, and 4 h. In GT1-7 cells, 10 Ϫ9 M Kiss produced an ϳ2-fold increase in Otx-2 mRNA levels after 2 h of treatment that continued through 4 h Figure 5 . A, Otx-2 mRNA expression in GT1-7 and GN11 cells modulated by Kiss (qRT-PCR). Graphic representation of the means Ϯ SE of relative mRNA graphed as fold increase of levels relative to NT cells. Cells were treated with 10 Ϫ9 M Kiss for 1, 2, and 4 h (n ϭ 3-4, p Յ 0.05). B, C, Otx-2 protein expression in GT1-7 and GN11 cells. Western blots were performed in a time course over 4 h after incubation with 10 Ϫ9 M kisspeptin. Total levels of ␤-actin were not altered by kisspeptin. The data were quantitated and the means Ϯ SE of relative densitometric values of protein graphed as fold increase of levels relative to NT cells are shown in the lower panels (bottom; n ϭ 3-4, p Յ 0.05). Asterisks indicate significant differences.
with an ϳ3-fold increase (n ϭ 3, p Յ 0.05; Fig. 5A ). In gonadotropin cells, 10 Ϫ9 M Kiss produced an ϳ2.5-fold increase in Otx-2 mRNA levels after 2 h of treatment that continued through 4 h by approximately a threefold increase (n ϭ 3-4, p Յ 0.05; Fig. 5A ). In agreement with previous studies, Otx-2 mRNA expression was expressed to a lesser extent in GN11 cells than in GT1-7 cells.
Otx-2 protein expression is increased by Kiss in GT1-7 and GN11 cells
To further evaluate the Otx-2 TF involvement in GnRH promoter activation by Kiss, GT1-7 and GN11 cells were incubated at different times (0.5, 1, 2, 3, and 4 h) with 10 Ϫ9 M Kiss, and expression of Otx-2 protein was measured by Western blot analysis (Fig. 5 B, C) . In both cell lines, Otx-2 was increased in a timedependent fashion from 30 min of treatment through 4 h (n ϭ 3; Fig. 5 A, B) . However, GT1-7 showed a faster response to Kiss treatment, reaching the maximal twofold increase at 1 h after treatment (n ϭ 3, p Յ 0.05; Fig. 5B ) since GN11 cells did reach the maximal twofold increase after 2 h of treatment (n ϭ 3, p Յ 0.05; Fig. 5C ). No significant changes in the total protein levels of ␤-actin were identified.
Kisspeptin was unable to increase LUC activity in GN11 and GT1-7 cells containing a mutated Otx-2 binding site within the KsRE GT1-7 and GN11 cells were transfected with the mGnRH promoter containing a mutated Otx-2 binding site in the KsRE located between Ϫ3005 and Ϫ3000 bp of the mGnRH promoter fused to the luciferase reporter gene. After transfection, cells were treated with 10 Ϫ9 M Kiss for 4 h. In GT1-7 and GN11 cells, no changes in LUC activities were observed after Kiss treatment; in contrast to the previous experiments using the Ϫ3446/ϩ23 bp of the mGnRH promoter (n ϭ 3-4, p Յ 0.05; Fig. 6 A, B) .
Kisspeptin was unable to increase hypothalamic GnRH mRNA expression in GnRH-Otx-2KO mice
GnRH mRNA levels were measured by qRT-PCR in hypothalamic tissue of control and GnRH-Otx-2KO mice. In wild-type mice, 1 nmol Kiss treatment produced an ϳ2-fold increase in hypothalamic GnRH mRNA levels (n ϭ 4, p Յ 0.05; Fig. 6C ). Consistent with the in vitro mutagenesis studies, no changes in hypothalamic GnRH expression were observed after Kiss treatment in GnRH-Otx-2KO animals (n ϭ 3, p Յ 0.05; Fig. 6C ).
Discussion
Evidence for a direct role of Kiss at the level of the GnRH neuron comes from in vivo anatomical studies (Han et al., 2005; Gottsch et al., 2006; Kauffman et al., 2007; Caraty and Franceschini, 2008; Roa et al., 2008a; Xu et al., 2011) and in vitro experiments performed in GnRH-expressing cell lines (Jacobi et al., 2007; Novaira et al., 2009 ). However, the molecular basis of GnRH regulation by Kiss remains unclear and thus requires further definition.
Using mouse-derived immortalized GnRH-secreting neuronal cell lines and transgenic mouse models, we investigate the role of Kiss in modulating GnRH transcription/translation activity. These studies provide in vitro and in vivo evidence that the region between Ϫ3446 to Ϫ2806 bp of the mGnRH gene is involved in the regulation of hypothalamic GnRH by Kiss, and that binding of the homeodomain TF, Otx-2, mediates this activation.
Although Kiss regulation of GnRH secretion is strongly supported by data from several manuscripts, its role on GnRH gene expression has more recently been elucidated. In fact, based on the use of inhibitors of transcription and translation in a GnRH Figure 6 . LUC expression in GT1-7 (A) and GN11 (B) cell lines transfected with Ϫ3446/ϩ23 bp mGnRH promoter and the Ϫ3446/ ϩ23mGnRHpromotercontainingthemutatedϪ3005/Ϫ3000Otx-2bindingsite(Ϫ3446/ϩ23bpmGnRHOtx-2Mut)fusedtotheLUC reporter gene. LUC expression was measured as RLUs in NT cells and treated with 10 Ϫ9 M Kiss for 4 h (n ϭ 3-4, p Յ 0.05). Asterisks indicate significant differences. C, Hypothalamic GnRH mRNA expression modulated by Kiss in wild-type and GnRH-Otx-2KO mice (qRT-PCR).GraphicrepresentationofthemeansϮSEofrelativemRNAgraphedasfoldincreaseoflevelsrelativetowild-type(WT)grouptreated withsaline.Micewereinjectedwithsalineor1nmolKissandhypothalamusharvestedafter20minofinjection(nϭ3-4,pՅ0.05).There is no statistical difference between groups with the same letters.
neuronal cell line, Pitts et al., 2001 suggested that cyclic GnRH synthesis was not necessary for pulse generation, while other studies have suggested that GnRH synthesis and secretion are closely coupled (Vazquez-Martinez et al., 2002; Novaira et al., 2009 ). These studies, including those from our laboratory, showed that Kiss increases GnRH mRNA levels (Jacobi et al., 2007; Novaira et al., 2009) . Hence, it is most likely that Kiss affects GnRH expression at both the secretory and pretranslational level to influence the onset of puberty and reproductive function.
Although GnRH mRNA was shown to increase in response to Kiss treatment in GnRH neuronal cell lines, the specific regions of the mGnRH promoter, TFs, and chromatin modifications that mediate Kiss action on GnRH gene expression were unknown. Hence, the goal was to use neuronal cell lines and transgenic mice to define the effect of Kiss. The GnRH promoter has previously been characterized in in vitro studies in conjunction with in vivo mapping using transgenic GnRH promoter reporter mice, to identify an NSE as well as enhancer element (GnRHen) important for neuronal GnRH gene expression (Eraly et al., 1998; Kim et al., 2007) . Also, previous studies have described the important interaction between the NSE and the GnRHen in gene activation (Nelson et al., 2000) . As previously shown, the GnRH promoter fragment (Ϫ3446 to ϩ23 bp) appears to contain all the elements needed for normal expression and regulation. In vitro, the Kiss effect on GnRH gene transcription was measured and a KsRE was localized. GT1-7 and GN11 cells transfected with sequential deletions of the mGnRH promoter fused to the LUC reporter gene identified a KsRE located within the region between Ϫ3446 to Ϫ2806 bp of the mGnRH promoter. Despite the insight gained from in vitro studies, cell culture is unlikely to reflect intricate signaling pathways regulating GnRH gene expression in vivo. Therefore, we have developed transgenic mice containing a series of GnRH promoter deletion constructs fused to reporter genes to study the regulation of the GnRH gene. In our in vivo studies, we were able to corroborate the presence of a KsRE located in the same region we described in cultured neuronal cell lines, within the region between Ϫ3446 to Ϫ2806 bp of the mGnRH promoter. Thus, the GnRHen is now functionally divided into two elements, the elements contained between Ϫ2806 and Ϫ2078 bp on the GnRHen are nKsRE responsive, while the sequences necessary to mediate the Kiss effects on neuronal mGnRH expression are contained between Ϫ3446 and Ϫ2806 bp of the GnRHen.
In order for transcription to proceed, modulation of chromatin structure is required. Inactive genes usually display condensed chromatin, while active genes and regulatory elements are often in an open chromatin conformation to facilitate binding of regulatory proteins (Sims et al., 2003; Kouzarides, 2007; Li et al., 2007) . To determine whether GnRH is subject to this modulation by Kiss was the goal of the next series of experiments. Two recent manuscripts had suggested that GnRH expression may be modulated by changes in chromatin structure and histone modifications (Kurian et al., 2010; Iyer et al., 2011) . Thus, we hypothesized that chromatin dynamics would then be regulated by the kisspeptin-GPR54 system. Genomic isolation of active regulatory elements (nucleosome-depleted DNA) was performed in GnRH neuronal cell lines treated with Kiss. Kisspeptin induced an active conformation of chromatin in the GnRH promoter within the KsRE (located between Ϫ3446 and Ϫ2806 bp upstream from the transcription start site). No changes of nucleosome-depleted DNA were observed within the GnRHen in the nKsRE (located between Ϫ2806 and Ϫ2078 bp) and in the NSE. Our results add to the growing body of evidence that the GnRH gene is a target of Kiss regulation.
Follow-up studies to identify the intranuclear messengers that mediate GPR54 signaling in the GnRH promoter were performed. Sequence analysis of the KsRE revealed two Otx-2 binding sites previously unidentified in these areas of the mGnRH promoter. The former is located between Ϫ3005 and Ϫ3000 bp (TAATCC) of the mGnRH promoter, which sequences had previously been shown located at the NSE and bind with high affinity to Otx-2 . The second Otx-2 binding site is located between Ϫ2417 to Ϫ2413 bp (TTATC), and these sequences were also described previously present in the NSE and shown to bind with low affinity to Otx-2 . Double-label immunohistochemistry has colocalized Otx-2 homeoprotein in GnRH neurons in mice (Mallamaci et al., 1996) . Furthermore, Otx-2 has been identified and was found to be necessary for expression of the GnRH gene (Kelley et al., 2000) . Elimination of Otx-2 binding sites in transgenic mice containing the proximal 356 bp fragment of the mGnRH promoter resulted in low hypothalamic luciferase expression, thus highlighting the important role of Otx-2 in neuronal tissue-specific expression of the mGnRH gene . In addition, deletion of Otx-2 in GnRH neurons results in a significant decrease in the number of GnRH neurons in the hypothalamus, low levels of GnRH, delay in pubertal onset, abnormal estrous cyclicity, and infertility in the GnRH neuron-specific Otx-2 KO (GnRHOtx2KO) mice (Diaczok et al., 2011) . Together, these data provide in vivo evidence that Otx-2 is critical for GnRH expression and reproductive competence. The GnRH-Otx2KO mice, albeit having ϳ80% fewer GnRH neurons in the hypothalamus than wild-type mice, were unable to increase GnRH mRNA expression after Kiss treatment, reinforcing the role of Otx-2 in Kiss signaling. Furthermore, Kiss increased Otx-2 mRNA and protein in the GnRH-expressing cell lines, and our results suggest that this newly described Otx-2 binding site is conserved across vertebrates.
In our studies, to assess the role of Otx-2 binding to the GnRH promoter in response to Kiss in the control of GnRH gene expres- Figure 7 . Model of potential molecular mechanisms for activation of GnRH transcription in GnRH neuron stimulated by Kiss. The potential interactions between the KsRE (red box), Otx-2 binding sites at the KsRE and the NSE (yellow boxes), and the Otx-2 transcription factor (dark green) are shown in B (direct Otx-2/Otx-2 interaction) and C (via unidentified bridging proteins, gray). These interactions (B or C) may exclude corepressors (in orange) such as groucho (Gro) proteins from binding to Otx-2 (A) to increase GnRH transcription.
sion, changes in Otx-2 binding to defined elements were evaluated. Otx-2 binding to the KsRE was significantly increased in cells treated with Kiss. However, Otx-2 occupancy on the consensus element in the NSE located between Ϫ356 and Ϫ249 bp of the mGnRH promoter was present but unchanged after Kiss treatment. These findings may be explained by nucleosome-depleted DNA levels observed in the NSE, which were present; however, none changed after kiss treatment in GT1-7 cells, suggesting the important role of Otx-2 in cell-specific gene expression. Additional studies documented the critical role of Otx-2 binding to the KsRE to mediate increases in GnRH promoter activity in response to Kiss. In vitro, transient transfection studies showed that Kiss was unable to activate expression from an Otx-2 binding site in the KsRE that was mutated.
Our previously published studies showed that phosphorylation of both mitogen-activated protein kinase (MAPK) and the phosphatidylinositol-3 kinase/Akt (PI3K/Akt) substrates are downstream targets of GPR54 activation by Kiss, regulating GnRH expression in GT1-7 and GN11 cell lines (Novaira et al., 2009 ). In addition, MAPK and PI3K/Akt pathways were shown to upregulate expression of several TFs including Otx-2 in Xenopus embryonic cells (Pera et al., 2001 (Pera et al., , 2003 . Furthermore, it was recently shown that histone deacetylases (HDACs) regulate GnRH-1 gene expression via modulating Otx-2-driven transcriptional activity (Gan et al., 2012) , suggesting a possible GPR54 signaling pathways to modulate GnRH expression in GnRH neurons.
Two models illustrating potential interactions between the Otx-2 TF, the KsRE, and the Otx-2 binding sites are shown in Figure 7 . Direct Otx-2/Otx-2 interaction or interactions via unidentified bridging proteins may exclude corepressors such as groucho (Gro) proteins (Malin et al., 2005; Rave-Harel et al., 2005; Larder and Mellon, 2009 ) from binding to Otx-2 increasing GnRH transcription. We postulate that such mechanisms would permit GnRH synthesis to remain coupled to GnRH secretion in response to Kiss.
In conclusion, these studies demonstrate the ability of Kiss to modify chromatin conformation and increase Otx-2 binding to a KsRE. This may be a mechanism to increase GnRH expression in response to Kiss during pubertal onset and reproductive cycling. Dysfunction of this critical pathway may explain pubertal disorders and mammalian infertility. This pathway may thus serve as a therapeutic target in humans.
